U.S. Energy Services Stock News

If you are wondering whether FormFactor's current share price lines up with its underlying worth, this article will walk you through what the numbers are actually saying. The stock recently closed at US$92.22, with returns of 2.6% over 7 days, a 2.5% decline over 30 days, 55.8% year to date and 196.4% over 1 year that may catch your eye. Recent coverage has focused on FormFactor as a semiconductor testing specialist, with investors watching how its technology and customer exposure position...

TG Therapeutics, ticker NasdaqCM:TGTX, announced a new five year, $750 million senior secured credit facility with Blue Owl Capital. The agreement is described as non dilutive, meaning it does not involve issuing new equity to raise capital. The facility includes repayment of prior debt and could expand to as much as $1b in total available financing. TG Therapeutics focuses on developing and commercializing therapies in the biopharmaceutical space, where access to sizeable, flexible capital...

Arthur J. Gallagher & Co. reported that director Sherry Barrat informed the company on March 6, 2026 of her decision to retire from the Board, effective May 12, 2026, after which the Board will shrink from ten to nine members. Her retirement, alongside recent analyst commentary, sharpens investor focus on how board composition and external views may shape oversight of the company’s ongoing growth plans and risk management priorities. We’ll now examine how RBC’s renewed positive coverage,...

Investors may be wondering whether Progress Software's current share price reflects its true value, or if the recent weakness is opening up an opportunity. The stock closed at US$31.29, with returns of an 8.8% decline over 7 days, a 22.4% decline over 30 days, a 23.8% decline year to date, and a 42.5% decline over 1 year. These moves may have shifted how the market views its risk and reward trade off. Recent headlines have focused on Progress Software's role as a software provider and how...

Sionna Therapeutics (SION) is back in focus for investors after recent trading left the shares with a return of about 166% over the past year, contrasting with weaker near term moves. See our latest analysis for Sionna Therapeutics. The share price is currently US$36.39, and short term share price returns over 1 and 3 months have been weak, yet the 1 year total shareholder return of about 166% points to strong earlier momentum that has recently cooled. If you are looking beyond a single...

Hamilton Lane (NasdaqGS:HLNE) has partnered with CenterSquare Investment Management to recapitalize Tenaya Village, a suburban Las Vegas retail center. The firm becomes the asset's majority investor, expanding its role in GP led secondary deals tied to essential service retail. The transaction signals active interest in real assets and alternative deal structures beyond traditional private credit and fund vehicles. Hamilton Lane enters this deal with its shares at $99.59 and a mixed return...

If you are wondering whether Walker & Dunlop at around US$43.82 is starting to look like value, the recent share performance gives plenty to think about. The stock has seen a 2.6% decline over the past week, a 30.7% decline over the last month, and returns of 25.4% year to date and 46.7% over the past year, with a 33.2% and 51.6% decline over the last 3 and 5 years respectively. These moves have put valuation front and center for many investors who are reassessing what they are willing to...

If you are wondering whether RPC at US$6.83 is priced attractively or not, the starting point is understanding what the current market price might be implying about its future. Over the short term, the stock has returned 4.8% in the last 7 days, 12.0% over 30 days, 23.5% year to date, 28.6% over 1 year, and 38.1% over 5 years, while the 3 year return sits at a 4.0% decline. Recent coverage around RPC has focused on how investors are reassessing energy service providers, with attention on...

For investors wondering whether Mirion Technologies at around US$18.45 offers real value or is mainly driven by headline excitement, this article walks through what the current price might be implying about the business. The stock has slipped around 1.3% over the last week and 13.3% over the last month, even though the 1 year return sits at 21.2% and the 3 year return reflects a very large gain from earlier levels. Recent coverage has focused on Mirion Technologies as a specialist in...

Chipotle Mexican Grill (NYSE:CMG) is rolling out new menu items and deeper customization to reignite its lunch business. The company is tying these changes to its digital channels and rewards program to increase customer frequency. Management is positioning Chipotle as more than a fast casual burrito chain, aiming to refresh the brand for younger guests. Chipotle operates a large fast casual restaurant chain focused on Mexican inspired food, with a heavy tilt toward burritos, bowls, tacos,...

Jack Henry & Associates (NasdaqGS:JKHY) received the “Small Business Payments Solution of the Year” award at the FinTech Breakthrough Awards for its Tap2Local product. The recognition focuses on Tap2Local, a cloud-native payments solution designed for small business clients of banks and credit unions. For investors watching NasdaqGS:JKHY, this award offers insight into how the company is positioning itself within digital payments for community and regional financial institutions. Tap2Local...

Leadership shake up and why it matters for HF Sinclair (DINO) HF Sinclair (DINO) has moved to permanently part ways with its CEO and CFO after earlier voluntary leaves. This is a material leadership change as the company conducts an internal review during a major growth phase. See our latest analysis for HF Sinclair. The leadership uncertainty comes after a strong run in the shares, with HF Sinclair’s 90 day share price return of 29.2% and 1 year total shareholder return of 87.6% suggesting...

Investors may be wondering whether CONMED's share price around US$35.94 reflects its true worth, or if the market has pushed it too far in one direction. The stock has seen weak recent returns, with a 3.6% decline over the last week, 20.4% over the last month, 11.3% year to date, and 39.3% over the past year. These moves can reshape how investors think about both risk and potential opportunity. Recent coverage has focused on CONMED as part of a broader look at medical equipment names, with...

Wondering whether Globant at US$44.71 is priced as a bargain or a value trap? This article walks you through what the current market price might be implying. The share price has had a tough run, with a 0.5% decline over 7 days, 2.4% decline over 30 days, 29.1% decline year to date and 65.8% decline over the last year. This will shape how you think about both potential growth and risk. These moves sit against a backdrop of ongoing interest in software and IT services companies, where many...

If you have been wondering whether DraftKings at around US$23.67 is starting to look like value or still carries too much risk, you are not alone. The stock has seen a mixed run, with a 6.1% gain over the last 30 days, an 8.5% decline over the last week, and returns of 33.5% over 3 years, 40.1% over 1 year, and 62.8% over 5 years. Recent headlines have focused on DraftKings' position in online sports betting and iGaming, as the sector continues to attract both regulation and competition...

To understand whether Waystar Holding at US$24.07 offers value or just looks cheap on the surface, you need to weigh the recent share performance against the fundamentals. Over the last week the stock returned 0.4% lower, over the last month it is 6.7% lower, and over the year it is 23.3% lower year to date and 35.8% lower over 1 year, which may signal that expectations and risk perceptions have shifted. Recent coverage has focused on Waystar Holding's position in healthcare services and...

Understanding Erasca’s Recent Share Performance Erasca (ERAS) has drawn fresh attention after a strong recent run in its share price, with the stock showing gains over the past week, month, past 3 months, and year to date. For context, Erasca is a clinical-stage precision oncology company focused on therapies targeting RAS/MAPK pathway-driven cancers. This is a niche that often attracts investors who track early-stage biotech pipelines and clinical milestones. See our latest analysis for...

In recent analyses, S&T Bancorp’s net interest income was found to have grown more slowly than the broader banking industry over the past five years and is now expected by sell-side analysts to decline by 5.3% in the coming 12 months, while earnings per share have fallen by 3.3% annually over the last two years on flat revenue. This combination of slowing core lending income and shrinking earnings, despite stable top-line performance, highlights ongoing pressure on the bank’s profitability...

Equinix has appointed Olivier Leonetti as its new Chief Financial Officer, succeeding Keith Taylor after 27 years in the role. Leonetti brings experience from large technology and infrastructure companies, including Eaton and Johnson Controls. The leadership change comes at an important time for Equinix and the wider data center and digital infrastructure sector. For investors watching NasdaqGS:EQIX, this CFO transition lands on top of a share price of $959.16 and a year-to-date return of...

Ryerson Holding (RYZ) has drawn investor attention after a period of weaker share performance, with the stock down over the past month and past 3 months despite its sizeable US metals processing footprint. See our latest analysis for Ryerson Holding. The 30 day share price return of 28.71% and 90 day return of 23.69% point to fading momentum. Meanwhile, the 1 year total shareholder return of 10.06% contrasts with a weaker 3 year total shareholder return of 37.54%, suggesting investors are...

Fluence Energy (NasdaqGS:FLNC) appointed Fahad Al-Darwish to its board of directors at its recent Annual Meeting. The company also filed a significant shelf registration, creating flexibility for potential future capital raising. Fluence Energy focuses on grid scale energy storage solutions, a segment that sits at the center of power system reliability and the integration of renewables. As battery technologies, grid modernization efforts, and policy support continue to shape the sector,...

Recent commentary on Columbia Sportswear highlights that, despite earlier stock outperformance, the company continues to face weak constant-currency revenue growth, flat free cash flow projections, and declining return on invested capital, pointing to soft demand and limited profitable expansion opportunities as of March 22, 2026. This combination of muted growth, constrained cash generation, and lower returns suggests that Columbia Sportswear may have fewer levers to improve its underlying...

If you are wondering whether Willis Lease Finance at around US$170.54 is still reasonably priced or starting to look stretched, the valuation numbers here are going to matter a lot. The stock has been volatile recently, with a 3.2% gain over the past week, a 15.5% decline over the last 30 days, a 27.2% return year to date, and a 6.0% loss over the past year, which can change how the market views both its potential and its risks. Recent news coverage has highlighted investor interest in...

If you are wondering whether Newmark Group's current share price still offers value, you are not alone. This article breaks down what the numbers are really saying about the stock. The share price closed at US$14.26 recently, with returns of 0.5% over 7 days, a 6.6% decline over 30 days, a 16.0% decline year to date, a 15.7% gain over 1 year, 127.9% over 3 years and 42.0% over 5 years. Together, these figures give you a mixed picture of recent momentum. That mix of short term weakness and...